CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias.
Vasilios C ConstantinidesGeorgios P ParaskevasFoteini BoufidouMara BourbouliEfstratios-Stylianos PyrgelisLeonidas StefanisElisabeth KapakiPublished in: Diagnostics (Basel, Switzerland) (2023)
in identifying AD pathology, irrespective of the clinical phenotype. CSF biomarker ratios and composite markers provide higher diagnostic accuracy compared to single CSF biomarkers.
Keyphrases